EssilorLuxottica and Burberry announce licensing partnership renewal EssilorLuxottica and Burberryannounce licensing partnership renewal Paris, France and London, United Kingdom (18 December 2025) – EssilorLuxottica and Burberry today announced the renewal of their licensing agreement for the development, production and global distribution of eyewear under the Burberry brand. The existing agreement, expiring on December 31, 2025, has been extended through December 31, 2035. Building on a shared legacy of creativity, craftsmanship and innovation, the renewal reinforces a long-standing pa...
EssilorLuxottica et Burberry renouvellent leur accord de licence EssilorLuxottica et Burberryrenouvellent leur accord de licence Paris, France et Londres, Royaume-Uni (18 décembre 2025) – EssilorLuxottica et Burberry ont annoncé aujourd’hui le renouvellement de leur accord de licence pour la conception, la production et la distribution mondiale de lunettes sous la marque Burberry. L’accord en vigueur, venant à échéance le 31 décembre 2025, a été prolongé jusqu’au 31 décembre 2035. S'appuyant sur une culture partagée de créativité, de savoir-faire et d'innovation, ce renouvellement vient...
EssilorLuxottica e Burberry rinnovano l’accordo di licenza EssilorLuxottica e Burberry rinnovano l’accordo di licenza Parigi, Francia e Londra, Regno Unito (18 dicembre 2025) – EssilorLuxottica e Burberry annunciano il rinnovo dell’accordo di licenza per lo sviluppo, la produzione e la distribuzione a livello globale di occhiali a marchio Burberry. L’accordo in essere, con scadenza prevista il 31 dicembre 2025, viene rinnovato fino al 31 dicembre 2035. Con una tradizione condivisa di creatività, artigianalità e innovazione, il rinnovo rafforza una collaborazione avviata tra le due socie...
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.